Table 1.
Virus | Vaccine Name | Vaccine Type | Developer |
---|---|---|---|
DENV | CYD-TDV (Dengvaxia) | Live attenuated | Sanofi Pasteur |
TDV (DENVax) * | Live attenuated | Takeda Vaccines Inc. | |
TV003/005 * | Live attenuated | NIH | |
JEV | SA14-14-2 | Live attenuated | BBIL, CDIBP |
JE-CV; ChimeriVax-JE | Chimeric | Acambis/Saofi Pasteur | |
BK-VJE; JE-MB; JE-VC | Inactivated | BIKEN | |
IXIARO | Inactivated | Valneva Austria GmbH | |
TBEV | FSME-Immun | Inactivated | Baxter |
Encepur | Inactivated | Novartis Vaccines | |
TBE-Moscow | Inactivated | Federal State Enterprise of Chumakov Institute of Poliomyelitis and Viral Encephalitides; Russian Academy of Medical Sciences | |
Encevir | Inactivated | Scientific Production Association Microgen | |
TBE-PHK | Inactivated | Sen TaiBao, China | |
YFV | 17DD | Live attenuated | Bio-Manguinhos (Fiocruz) |
17D-204 | Live attenuated | Sanofi Pasteur; Institute Pasteur; Wuhan Institute of Biological Products, China | |
17D-213 | Live attenuated | Federal State Unitary Enterprise of Chumakov Institute, Russia |
* Not licensed but at the advanced stages of clinical development.